249 related articles for article (PubMed ID: 21338638)
21. Analysis of IL-10, IL-4 and TNF-alpha polymorphisms in drug-induced liver injury (DILI) and its outcome.
Pachkoria K; Lucena MI; Crespo E; Ruiz-Cabello F; Lopez-Ortega S; Fernandez MA; Romero-Gomez M; Madrazo A; Durán JA; de Dios AM; Borraz Y; Navarro JM; Andrade RJ;
J Hepatol; 2008 Jul; 49(1):107-14. PubMed ID: 18485518
[TBL] [Abstract][Full Text] [Related]
22. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period.
Andrade RJ; Lucena MI; Fernández MC; Pelaez G; Pachkoria K; García-Ruiz E; García-Muñoz B; González-Grande R; Pizarro A; Durán JA; Jiménez M; Rodrigo L; Romero-Gomez M; Navarro JM; Planas R; Costa J; Borras A; Soler A; Salmerón J; Martin-Vivaldi R;
Gastroenterology; 2005 Aug; 129(2):512-21. PubMed ID: 16083708
[TBL] [Abstract][Full Text] [Related]
23. Nitrofurantoin-induced liver injury: long-term follow-up in two prospective DILI registries.
Bessone F; Ferrari A; Hernandez N; Mendizabal M; Ridruejo E; Zerega A; Tanno F; Reggiardo MV; Vorobioff J; Tanno H; Arrese M; Nunes V; Tagle M; Medina-Caliz I; Robles-Diaz M; Niu H; Alvarez-Alvarez I; Stephens C; Lucena MI; Andrade RJ
Arch Toxicol; 2023 Feb; 97(2):593-602. PubMed ID: 36416910
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathological Study of Autoimmune Hepatitis Cases That Were Difficult to Differentiate from Drug-Induced Liver Injury.
Tsutsui A; Harada K; Tsuneyama K; Senoh T; Nagano T; Takaguchi K; Ando M; Nakamura S; Mizobuchi K; Kudo M
Dig Dis; 2017; 35(6):506-514. PubMed ID: 29040982
[TBL] [Abstract][Full Text] [Related]
25. Clinical Characteristics of Patients with Drug-induced Liver Injury.
Yang LX; Liu CY; Zhang LL; Lai LL; Fang M; Zhang C
Chin Med J (Engl); 2017 Jan; 130(2):160-164. PubMed ID: 28091407
[TBL] [Abstract][Full Text] [Related]
26. Antituberculous drug-induced liver injury: current perspective.
Devarbhavi H
Trop Gastroenterol; 2011; 32(3):167-74. PubMed ID: 22332331
[TBL] [Abstract][Full Text] [Related]
27. Clinical Characteristics and Outcome of Drug-Induced Liver Injury in the Older Patients: From the Young-Old to the Oldest-Old.
Weersink RA; Alvarez-Alvarez I; Medina-Cáliz I; Sanabria-Cabrera J; Robles-Díaz M; Ortega-Alonso A; García-Cortés M; Bonilla E; Niu H; Soriano G; Jimenez-Perez M; Hallal H; Blanco S; Kaplowitz N; Lucena MI; Andrade RJ
Clin Pharmacol Ther; 2021 Apr; 109(4):1147-1158. PubMed ID: 33179256
[TBL] [Abstract][Full Text] [Related]
28. Drug-induced autoimmune liver disease: A diagnostic dilemma of an increasingly reported disease.
Castiella A; Zapata E; Lucena MI; Andrade RJ
World J Hepatol; 2014 Apr; 6(4):160-8. PubMed ID: 24799984
[TBL] [Abstract][Full Text] [Related]
29. Necrotic cell death and suppression of T-cell immunity characterized acute liver failure due to drug-induced liver injury.
Kakisaka K; Kataoka K; Suzuki Y; Okada Y; Yoshida Y; Kuroda H; Takikawa Y
Cytokine; 2016 Oct; 86():21-28. PubMed ID: 27442007
[TBL] [Abstract][Full Text] [Related]
30. Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury.
Robles-Diaz M; Lucena MI; Kaplowitz N; Stephens C; Medina-Cáliz I; González-Jimenez A; Ulzurrun E; Gonzalez AF; Fernandez MC; Romero-Gómez M; Jimenez-Perez M; Bruguera M; Prieto M; Bessone F; Hernandez N; Arrese M; Andrade RJ; ; ;
Gastroenterology; 2014 Jul; 147(1):109-118.e5. PubMed ID: 24704526
[TBL] [Abstract][Full Text] [Related]
31. Hepatotoxicity associated with statin use: analysis of the cases included in the Spanish Hepatotoxicity Registry.
Perdices EV; Medina-Cáliz I; Hernando S; Ortega A; Martín-Ocaña F; Navarro JM; Peláez G; Castiella A; Hallal H; Romero-Gómez M; González-Jiménez A; Robles-Díaz M; Lucena MI; Andrade RJ
Rev Esp Enferm Dig; 2014 Apr; 106(4):246-54. PubMed ID: 25075655
[TBL] [Abstract][Full Text] [Related]
32. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland.
Björnsson ES; Bergmann OM; Björnsson HK; Kvaran RB; Olafsson S
Gastroenterology; 2013 Jun; 144(7):1419-25, 1425.e1-3; quiz e19-20. PubMed ID: 23419359
[TBL] [Abstract][Full Text] [Related]
33. Clinical and histological features of idiosyncratic liver injury: Dilemma in diagnosis of autoimmune hepatitis.
Kuzu UB; Öztaş E; Turhan N; Saygili F; Suna N; Yildiz H; Kaplan M; Akpinar MY; Akdoğan M; Kaçar S; Kiliç ZM; Köksal AŞ; Ödemiş B; Kayaçetin E
Hepatol Res; 2016 Apr; 46(4):277-91. PubMed ID: 25926402
[TBL] [Abstract][Full Text] [Related]
34. Early ALT response to corticosteroid treatment distinguishes idiosyncratic drug-induced liver injury from autoimmune hepatitis.
Weber S; Benesic A; Rotter I; Gerbes AL
Liver Int; 2019 Oct; 39(10):1906-1917. PubMed ID: 31319011
[TBL] [Abstract][Full Text] [Related]
35. Distinct phenotype of hepatotoxicity associated with illicit use of anabolic androgenic steroids.
Robles-Diaz M; Gonzalez-Jimenez A; Medina-Caliz I; Stephens C; García-Cortes M; García-Muñoz B; Ortega-Alonso A; Blanco-Reina E; Gonzalez-Grande R; Jimenez-Perez M; Rendón P; Navarro JM; Gines P; Prieto M; Garcia-Eliz M; Bessone F; Brahm JR; Paraná R; Lucena MI; Andrade RJ; ;
Aliment Pharmacol Ther; 2015 Jan; 41(1):116-25. PubMed ID: 25394890
[TBL] [Abstract][Full Text] [Related]
36. Rechallenge in idiosyncratic drug-induced liver injury: An analysis of cases in two large prospective registries according to existing definitions.
Pinazo-Bandera JM; Niu H; Alvarez-Alvarez I; Medina-Cáliz I; Del Campo-Herrera E; Ortega-Alonso A; Robles-Díaz M; Hernández N; Paraná R; Nunes V; Girala M; Bessone F; Lucena MI; Andrade RJ; García Cortés M
Pharmacol Res; 2024 May; 203():107183. PubMed ID: 38631619
[TBL] [Abstract][Full Text] [Related]
37. The characteristics and clinical outcome of drug-induced liver injury: a single-center experience.
Idilman R; Bektas M; Cinar K; Toruner M; Cerit ET; Doganay B; Erden E; Bozkaya H; Bahar K; Karayalcin S; Soykan I; Palabiyikoglu M; Cetinkaya H; Yurdaydin C; Dokmeci A; Ozden A
J Clin Gastroenterol; 2010 Jul; 44(6):e128-32. PubMed ID: 20551776
[TBL] [Abstract][Full Text] [Related]
38. Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex.
Lucena MI; Andrade RJ; Kaplowitz N; García-Cortes M; Fernández MC; Romero-Gomez M; Bruguera M; Hallal H; Robles-Diaz M; Rodriguez-González JF; Navarro JM; Salmeron J; Martinez-Odriozola P; Pérez-Alvarez R; Borraz Y; Hidalgo R;
Hepatology; 2009 Jun; 49(6):2001-9. PubMed ID: 19475693
[TBL] [Abstract][Full Text] [Related]
39. [Clinical analysis of protionamide and para-aminosalicylic acid induced hepatotoxicity in 129 cases].
Ge QP; Wang QF; Duan HF; Wang J; Chu NH
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Oct; 36(10):737-40. PubMed ID: 24433800
[TBL] [Abstract][Full Text] [Related]
40. Top-ranking drugs out of 3312 drug-induced liver injury cases evaluated by the Roussel Uclaf Causality Assessment Method.
Teschke R
Expert Opin Drug Metab Toxicol; 2018 Nov; 14(11):1169-1187. PubMed ID: 30354694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
